Objectives:

1. Describe the use of IV ketamine as an adjuvant analgesia to opioids for cancer pain

2. Discuss the clinical trial data for use of IV ketamine in cancer pain
3. Discuss the toxicities associated with IV ketamine

Session date: 
Thursday, January 4, 2018 - 8:00am to 9:00am
Speaker Name: 
Michael Huber, MD
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.